| Literature DB >> 18491049 |
A Gluch1, M Vidakovic, J Bode.
Abstract
There is increasing awareness that processes, such as development, aging and cancer, are governed, to a considerable extent, by epigenetic processes, such as DNA and histone modifications. The sites of these modifications in turn reflect their position and role in the nuclear architecture. Since epigenetic changes are easier to reverse than mutations, drugs that remove or add the chemical tags are at the forefront of research for the treatment of cancerous and inflammatory diseases. This review will use selected examples to develop a unified view that might assist the systematic development of novel therapeutic regimens.Entities:
Mesh:
Substances:
Year: 2008 PMID: 18491049 DOI: 10.1007/978-3-540-72843-6_4
Source DB: PubMed Journal: Handb Exp Pharmacol ISSN: 0171-2004